Le Lézard

Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules

Citius Oncology, Inc. ("Citius Oncology" or the "Company") , the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ...